EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ellagic Acid Prevented Dextran-Sodium-Sulfate-Induced Colitis, Liver, and Brain Injury through Gut Microbiome Changes

Dong-Ha Kim, Ji-Su Kim, Jae-Hee Kwon iD, In-Sook Kwun, Moon-Chang Baek, Gi-Seok Kwon, Wiramon Rungratanawanich, Byoung-Joon Song iD, Do-Kyun Kim, Hyo-Jung Kwon, Young-Eun Cho iD

Antioxidants · 20.10.2023 · 12 (10) · 1886

DOI: 10.3390/antiox12101886 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 20.10.2023. Verfasst von Dong-Ha Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, School of Medicine, Cell & Matrix Research Institute, Kyungpook National University, Daegu 41566, Republic of Korea. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Marketing and Social Information Technology, National Research Foundation of Korea (NRF), Intramural Research Fund of National Institute on Alcohol Abuse and Alcoholism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) affects millions of people worldwide and is considered a significant risk factor for colorectal cancer. Recent in vivo and in vitro studies reported that ellagic acid (EA) exhibits important antioxidant and anti-inflammatory properties. In this study, we investigated the preventive effects of EA against dextran sulfate sodium (DSS)-induced acute colitis, liver, and brain injury in mice through the gut–liver–brain axis. Acute colitis, liver, and brain injury were induced by treatment with 5% (w/v) DSS in the drinking water for 7 days. Freshly prepared EA (60 mg/kg/day) was orally administered, while control (CON) group mice were treated similarly by daily oral administrations with a vehicle (water). All the mice were euthanized 24 h after the final treatment with EA. The blood, liver, colon, and brain samples were collected for further histological and biochemical analyses. Co-treatment with a physiologically relevant dose (60 mg/kg/day) of EA for 7 days significantly reduced the DSS-induced gut barrier dysfunction; endotoxemia; and inflammatory gut, liver, and brain injury in mice by modulating gut microbiota composition and inhibiting the elevated oxidative and nitrative stress marker proteins. Our results further demonstrated that the preventive effect of EA on the DSS-induced IBD mouse model was mediated by blocking the NF-κB and mitogen-activated protein kinase (MAPK) pathway. Therefore, EA co-treatment significantly attenuated the pro-inflammatory and oxidative stress markers by suppressing the activation of NF-κB/MAPK pathways in gut, liver, and brain injury. These results suggest that EA, effective in attenuating IBD in a mouse model, deserves further consideration as a potential therapeutic for the treatment of inflammatory diseases.

Schlagwörter

Stichwörter der Autor:innen

NF-κB/MAPK activationanti-inflammationantioxidantdextran sulfate sodiumellagic acidinflammatory bowel disease

Autor:innen und Institutionen

  • Department of Molecular Medicine, School of Medicine, Cell & Matrix Research Institute, Kyungpook National University, Daegu 41566, Republic of Korea.
  • Department of Food and Nutrition, Andong National University, Andong 1375, Republic of Korea.
  • Department of Horticulture & Medicinal Plant, Andong National University, Andong 1375, Republic of Korea.
  • Section of Molecular Pharmacology and Toxicology, Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA.
  • Korea Zoonosis Research Institute, Jeonbuk National University, Iksan 54596, Republic of Korea.
  • Department of Veterinary Pathology, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea.

ORCID-Profile: Jae-Hee Kwon, Byoung-Joon Song, Young-Eun Cho

Förderung

  • Institute of Marketing and Social Information Technology
  • National Research Foundation of Korea (NRF)
  • Intramural Research Fund of National Institute on Alcohol Abuse and Alcoholism

Zitieren

APA

Kim, D. H., Kim, J. S., Kwon, J. H., Kwun, I. S., Baek, M. C., Kwon, G. S., Rungratanawanich, W., Song, B. J., Kim, D. K., Kwon, H. J., & Cho, Y. E. (2023). Ellagic Acid Prevented Dextran-Sodium-Sulfate-Induced Colitis, Liver, and Brain Injury through Gut Microbiome Changes. Antioxidants, 12(10), 1886. https://doi.org/10.3390/antiox12101886

Vancouver

Kim DH, Kim JS, Kwon JH, Kwun IS, Baek MC, Kwon GS, et al. Ellagic Acid Prevented Dextran-Sodium-Sulfate-Induced Colitis, Liver, and Brain Injury through Gut Microbiome Changes. Antioxidants. 2023;12(10):1886. doi:10.3390/antiox12101886

BibTeX
@article{Kim2023,
  author = {Kim, Dong-Ha and Kim, Ji-Su and Kwon, Jae-Hee and Kwun, In-Sook and Baek, Moon-Chang and Kwon, Gi-Seok and Rungratanawanich, Wiramon and Song, Byoung-Joon and Kim, Do-Kyun and Kwon, Hyo-Jung and Cho, Young-Eun},
  title = {Ellagic Acid Prevented Dextran-Sodium-Sulfate-Induced Colitis, Liver, and Brain Injury through Gut Microbiome Changes},
  journal = {Antioxidants},
  year = {2023},
  volume = {12},
  number = {10},
  pages = {1886},
  doi = {10.3390/antiox12101886}
}
Kostenlos starten →